DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Materials
Author Program NEWCreate Narrative
BIOX logo

Bioceres Crop Solutions Corp. Stock Price

NasdaqGS:BIOX Community·US$23.4m Market Cap
  • 3 Narratives written by author
  • 2 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

BIOX Share Price Performance

US$0.36
-1.31 (-78.43%)
​
US$2.25
Fair Value
US$0.36
-1.31 (-78.43%)
84.0% undervalued intrinsic discount
US$2.25
Fair Value
Price US$0.36
AnalystConsensusTarget US$2.25
AnalystLowTarget US$2.50
AnalystHighTarget US$8.00
Wed, 17 Dec 25
Fair ValueUS$2.25
Share Pricen/a

BIOX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$2.25 84.0% undervalued intrinsic discount

BIOX: Recovery From Argentina Volatility Will Drive Future Upside Potential

1users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$2.5 85.6% undervalued intrinsic discount

Leverage And Argentina Risks Will Impede Performance But Spur Recovery

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$8 95.5% undervalued intrinsic discount

Sustainable Agriculture And Decarbonization Will Advance HB4 Crop Adoption

1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
BIOX logo
Bioceres Crop Solutions
84.0% undervalued intrinsic discount

BIOX: Recovery From Argentina Volatility Will Drive Future Upside Potential

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 17 Dec 2025
Read Narrative
BIOX logo
Bioceres Crop Solutions
85.6% undervalued intrinsic discount

Leverage And Argentina Risks Will Impede Performance But Spur Recovery

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 22 Jun 2025
Read Narrative
BIOX logo
Bioceres Crop Solutions
95.5% undervalued intrinsic discount

Sustainable Agriculture And Decarbonization Will Advance HB4 Crop Adoption

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 1 Jun 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
BIOX logo

BIOX: Portfolio Recapitalization Progress Will Eventually Overcome Argentina Liquidity Headwinds

Fair Value: US$2.25 84.0% undervalued intrinsic discount
16 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
BIOX logo

Leverage And Argentina Risks Will Impede Performance But Spur Recovery

Fair Value: US$2.5 85.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
BIOX logo

Sustainable Agriculture And Decarbonization Will Advance HB4 Crop Adoption

Fair Value: US$8 95.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with very low risk.

2 Risks
1 Reward
View Full Analysis

Bioceres Crop Solutions Corp. Key Details

US$237.8m

Revenue

US$155.3m

Cost of Revenue

US$82.5m

Gross Profit

US$129.4m

Other Expenses

-US$46.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.74
34.69%
-19.72%
352.4%
View Full Analysis

About BIOX

Founded
2001
Employees
751
CEO
Federico Trucco
WebsiteView website
investors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Recent BIOX News & Updates

Recent updates

No updates

Bioceres Crop Solutions Corp. Competitors

NWGL logo

CL Workshop Group

Symbol: NasdaqCM:NWGL
Market cap: US$46.5m
AABB logo

Asia Broadband

Symbol: OTCPK:AABB
Market cap: US$44.8m
XTPT logo

Xtra Energy

Symbol: OTCPK:XTPT
Market cap: US$37.6m
CGLD logo

Buscar

Symbol: OTCPK:CGLD
Market cap: US$32.3m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide